Intracranial Hemangiopericytoma – A Case Report
Hemangiopericytoma is a rare mesenchymal tumor, considered as a subtype of soft tissue sarcomas with an incidence of 3.77/10.000.000 cases. Intracranial hemangiopericytomas account for less than 1% of all primary tumors of the central nervous system. Due to the lack of data available regarding this...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
West Asia Organization for Cancer Prevention
2020-12-01
|
| Series: | Asian Pacific Journal of Cancer Care |
| Subjects: | |
| Online Access: | http://www.waocp.com/journal/index.php/apjcc/article/view/490 |
| _version_ | 1797344237251985408 |
|---|---|
| author | Gilson Gabriel Viana Veloso Raul de Almeida Dutra Letícia de Almeida Dutra Pedro Teixeira Meireles Douglas Reis Abdalla Luiz Carlos Furtado de Almeida Júnior |
| author_facet | Gilson Gabriel Viana Veloso Raul de Almeida Dutra Letícia de Almeida Dutra Pedro Teixeira Meireles Douglas Reis Abdalla Luiz Carlos Furtado de Almeida Júnior |
| author_sort | Gilson Gabriel Viana Veloso |
| collection | DOAJ |
| description | Hemangiopericytoma is a rare mesenchymal tumor, considered as a subtype of soft tissue sarcomas with an incidence of 3.77/10.000.000 cases. Intracranial hemangiopericytomas account for less than 1% of all primary tumors of the central nervous system. Due to the lack of data available regarding this disease, national and international research provides information derived from retrospective case series and phase I and phase II studies. This is a case report of a young adult diagnosed with intracranial hemangiopericytoma in 2012 with a history of multiple recurrences and therapeutic approaches, assisted in a public health center in southeastern Brazil. Among the treatment options given to the patient, there are surgery, radiotherapy, and systemic chemotherapy (including alkylating and anthracyclines agents). Systemic therapy usually is offered after multiple recurrences or in a metastatic setting; although it increases progression-free survival, there is not enough data on objective response rate and does not yield increased overall survival. |
| first_indexed | 2024-03-08T10:59:27Z |
| format | Article |
| id | doaj.art-b43e28cd5ee34ae7bdfd91dcb7e3f0ec |
| institution | Directory Open Access Journal |
| issn | 2588-3682 |
| language | English |
| last_indexed | 2024-03-08T10:59:27Z |
| publishDate | 2020-12-01 |
| publisher | West Asia Organization for Cancer Prevention |
| record_format | Article |
| series | Asian Pacific Journal of Cancer Care |
| spelling | doaj.art-b43e28cd5ee34ae7bdfd91dcb7e3f0ec2024-01-26T16:09:50ZengWest Asia Organization for Cancer PreventionAsian Pacific Journal of Cancer Care2588-36822020-12-015435135410.31557/apjcc.2020.5.4.351-354490Intracranial Hemangiopericytoma – A Case ReportGilson Gabriel Viana Veloso0Raul de Almeida Dutra1Letícia de Almeida Dutra2Pedro Teixeira Meireles3Douglas Reis Abdalla4Luiz Carlos Furtado de Almeida Júnior5Clinic Oncology, Hospital Santa Casa de Belo HorizonteClinic Oncology, Hospital Doutor Hélio AngottiMedicine Course, Universidade de UberabaMedicine Course, Universidade de UberabaFaculty of Human TalentCancer Surgery, Hospital Doutor Hélio AngottiHemangiopericytoma is a rare mesenchymal tumor, considered as a subtype of soft tissue sarcomas with an incidence of 3.77/10.000.000 cases. Intracranial hemangiopericytomas account for less than 1% of all primary tumors of the central nervous system. Due to the lack of data available regarding this disease, national and international research provides information derived from retrospective case series and phase I and phase II studies. This is a case report of a young adult diagnosed with intracranial hemangiopericytoma in 2012 with a history of multiple recurrences and therapeutic approaches, assisted in a public health center in southeastern Brazil. Among the treatment options given to the patient, there are surgery, radiotherapy, and systemic chemotherapy (including alkylating and anthracyclines agents). Systemic therapy usually is offered after multiple recurrences or in a metastatic setting; although it increases progression-free survival, there is not enough data on objective response rate and does not yield increased overall survival.http://www.waocp.com/journal/index.php/apjcc/article/view/490hemangiopericytomasarcomaoncologytumor |
| spellingShingle | Gilson Gabriel Viana Veloso Raul de Almeida Dutra Letícia de Almeida Dutra Pedro Teixeira Meireles Douglas Reis Abdalla Luiz Carlos Furtado de Almeida Júnior Intracranial Hemangiopericytoma – A Case Report Asian Pacific Journal of Cancer Care hemangiopericytoma sarcoma oncology tumor |
| title | Intracranial Hemangiopericytoma – A Case Report |
| title_full | Intracranial Hemangiopericytoma – A Case Report |
| title_fullStr | Intracranial Hemangiopericytoma – A Case Report |
| title_full_unstemmed | Intracranial Hemangiopericytoma – A Case Report |
| title_short | Intracranial Hemangiopericytoma – A Case Report |
| title_sort | intracranial hemangiopericytoma a case report |
| topic | hemangiopericytoma sarcoma oncology tumor |
| url | http://www.waocp.com/journal/index.php/apjcc/article/view/490 |
| work_keys_str_mv | AT gilsongabrielvianaveloso intracranialhemangiopericytomaacasereport AT rauldealmeidadutra intracranialhemangiopericytomaacasereport AT leticiadealmeidadutra intracranialhemangiopericytomaacasereport AT pedroteixeirameireles intracranialhemangiopericytomaacasereport AT douglasreisabdalla intracranialhemangiopericytomaacasereport AT luizcarlosfurtadodealmeidajunior intracranialhemangiopericytomaacasereport |